510(k) K902208

MODIFIED OVUGEN by Biogenex Laboratories — Product Code CEP

K902208 is an FDA 510(k) premarket notification submitted by Biogenex Laboratories for the device "MODIFIED OVUGEN". The FDA issued a decision of Substantially Equivalent on July 17, 1990. The device falls under product code CEP (Radioimmunoassay, Luteinizing Hormone), a Class I device regulated under 21 CFR 862.1485. Biogenex Laboratories has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
July 17, 1990
Date Received
May 16, 1990
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Radioimmunoassay, Luteinizing Hormone
Device Class
Class I
Regulation Number
862.1485
Review Panel
CH
Submission Type